Zimbro or common juniper (Juniperus communis) is traditionally used to treat renal suppression, acute and chronic cystitis, bladder catarrh, albuminuria, leucorrhea, and amenorrhea. These uses are mainly attributed to its bioactive composition, which is very rich in phenolics, terpenoids, organic acids, alkaloids, and volatile compounds. In the last few years, several studies have analyzed the huge potential of this evergreen shrub, describing a wide range of activities with relevance in different biomedical discipline areas, namely antimicrobial potential against human pathogens and foodborne microorganisms, notorious antioxidant and anti-inflammatory activities, antidiabetic, antihypercholesterolemic and antihyperlipidemic effects, and neuroprotective action, as well as antiproliferative ability against cancer cells and the ability to activate inductive hepato-, renal- and gastroprotective mechanisms.
Gender |
Origin |
Extract |
Total Phenolic Compounds a |
Total Flavonoid Content b |
Total Anthocyanin Content c |
Total Tannin Content b |
References |
|
---|---|---|---|---|---|---|---|---|
Leaves |
||||||||
J. communis (var. alpina) |
n.s. |
Serra Da Estrela, Portugal |
Methanolic (100%, v/v) |
155.60 |
60.40 |
[64] |
||
J. communis (var. alpina) |
n.s. |
Yozgat, Turkey |
Hydroethanolic (80% ethanol, v/v) |
4.36 |
7.05 |
[61] |
||
J. communis (var. alpina) |
n.s. |
Yozgat, Turkey |
Aqueous |
169.27 |
24.30 |
|||
J. communis (var. communis) |
Female |
Rhodopes, Bulgaria |
Methanolic (80% methanol, v/v) |
132.00 |
[60] |
|||
J. communis (var. communis) |
Female |
Mountain Ozren, near Sarajevo, Bosnia, and Herzegovina |
Methanolic (80% methanol, v/v) |
390.89 |
40.22 * |
[62] |
||
J. communis (var. communis) |
Male |
Mountain Ozren, near Sarajevo, Bosnia, and Herzegovina |
Methanolic (80% methanol, v/v) |
544.09 |
48.06 * |
|||
J. communis (var. communis) |
n.s. |
Nainital, India |
Hydroethanolic (70% ethanol, v/v) |
238.78 |
[65] |
|||
J. communis (var. communis) |
n.s. |
Nainital, India |
Hexane |
189.65 |
||||
J. communis (var. communis) |
n.s. |
Nainital, India |
Ethyl acetate |
315.33 |
||||
J. communis (var. communis) |
n.s. |
Nainital, India |
Aqueous |
205.33 |
||||
J. communis (var. oblonga pendula) |
Male |
North Carolina, USA |
Methanolic (80% methanol, v/v) |
91.00 |
[60] |
|||
J. communis (var. saxatiles) |
n.s. |
Turkey |
Hydroethanolic (80% ethanol, v/v) |
212.10 |
[66] |
|||
Berries |
||||||||
J. communis (var. alpina) |
n.s. |
Yozgat, Turkey |
Hydroethanolic (80% ethanol, v/v) |
Ripe berry: 11.92 Unripe berry: 130.92 |
Ripe berry: 2.56 Unripe berry: 17.57 |
[61] |
||
J. communis (var. alpina) |
n.s. |
Yozgat, Turkey |
Aqueous |
Ripe berry: 4.36 |
Ripe berry: 7.05 |
|||
J. communis (var. communis) |
North-East Slovakia |
Hydroethanolic (70% ethanol, v/v) |
Ripe berry: 6.87–42.23 |
[67] |
||||
J. communis (var. communis) |
n.s. |
Melbourne, Australia |
Hydroethanolic (30% ethanol, v/v) |
Ripe berry: 9.08 |
Ripe berry: 2.25 |
Ripe berry: 3.48 * |
[68] |
|
J. communis (var. communis) |
n.s. |
Quebec, Canada |
Hydroethanolic (80% ethanol, v/v) |
Ripe berry: 99.20 b |
Ripe berry: 0.47 |
[69] |
||
J. communis (var. communis) |
n.s. |
Serra Da Estrela, Portugal |
Methanolic (100%, v/v) |
Ripe berry: 44.70 |
[64] |
|||
J. communis (var. communis) |
n.s. |
Ağrı, Turkey |
Methanolic (100%, v/v) |
Ripe berry: 59.17 |
[70] |
|||
J. communis (var. n.s.) |
n.s. |
Pitesti hills, Romania |
Hydroethanolic (50% ethanol, v/v) |
Ripe berry: 0.19 |
Ripe berry: 51.09 d |
[40] |
||
J. communis (var. saxatilis) |
n.s. |
Yozgat, Turkey |
Hydroethanolic (80% ethanol, v/v) |
Ripe berry: 21.00 |
[66] |
|||
J. communis (var. saxatilis) |
n.s. |
Ankara, Turkey |
Methanolic (100%, v/v) |
Ripe berry: 17.64 |
[70] |
|||
J. communis (n.s.) |
n.s. |
Šara mountain in south Serbia |
Chloroformic |
189.82 |
27.11 d |
[50] |
||
J. communis (var. n.s.) |
n.s. |
Šara mountain in south Serbia |
Ethanolic |
189.82 |
42.85 d |
|||
J. communis (var. n.s.) |
n.s. |
Šara mountain in south Serbia |
Ethyl acetate |
144.21 |
38.40 d |
|||
Stems |
||||||||
J. communis (var. alpina) |
n.s. |
Serra Da Estrela, Portugal |
Methanolic (100%, v/v) |
221.30 |
79.30 |
[64] |
Part of the Plant |
Origin |
Subspecies/Variety |
Method |
Inhibited Species |
References |
---|---|---|---|---|---|
Antimicrobial activity |
|||||
Essential oils |
|||||
Berries |
Poland |
n.s. |
Disc diffusion |
Staphyllococcus aureus, Serratia marcenscens, Enterobacter cloace, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumanii, Listeria monocytogenes, and Candida albicans |
[89] |
Needles |
Portugal |
var. alpina |
MIC and MLC |
Epidermophyton floccosum, Microsporum canis, M. gypseum, Trichophyton mentagrophytes, T. mentagrophytes var. interdigitale, T. rubrum, and T. verrucosum |
[90] |
Needles and berries |
Italy |
var. communis |
MIC |
C. albicans, S. aureus, and P. aeuroginosa |
[91] |
Plant material (leaves and stems) |
Iran |
n.s. |
Disc diffusion |
S. aureus, P. aeruginosa, and E. coli |
[36] |
Berries |
Slovenia |
n.s. |
Biofims assay |
Campylobacter jejuni, L. monocytogenes |
[96] |
Plant material (undifferentiated) |
Slovenia |
n.s. |
Disc diffusion |
S. aureus and C. albicans |
[92] |
Berries |
Spain |
n.s. |
MIC |
E. coli, Proteus mirabilis, K. pneumoniae, P. aeruginosa and Morganella morganii, MRSA, and L. monocytogenes |
[75] |
Berries |
Portugal |
n.s. |
MIC and MLC |
B. cereus, B. subtilis, E. aerogenes, E. faecalis, E. coli, K. pneumoniae, Proteus mirabilis, P. aeruginosa, Salmonella typhimurium, S. aureus, and C. albicans |
[81] |
Leaves |
Croatia |
n.s. |
Disc diffusion, MIC, and MLC |
16 species of bacteria and 14 species of fungus |
[26] |
Berries |
Serbia |
n.s. |
Disc diffusion, MIC, MLC, and in vivo adhesion assay |
S. aureus, MRSA, E. faecalis, L. monocytogenes, E. coli, S. flexneri, S. enteritidis, P. aeruginosa, Aspergillus fumigatus, A. versicolor, A. ochraceus, A. niger, Trichoderma viride, Penicillium funiculosum, P. ochrochloron, and P. verrucosum var. cyclopium |
[93] |
Plant material (leaves and branches) |
Egypt |
n.s. |
MIC |
S. aureus, E. coli, and C. albicans |
[94] |
Plant material |
Croatia |
n.s. |
MIC and biofilm assay |
Mycobacterium avium, M. intracellulare, and M. gordonae |
|
Phenolic-rich extracts |
|||||
Berries |
Slovenia |
n.s. |
Biofilms assay |
C. jejuni, L. monocytogenes |
[96] |
Plant material |
Italy |
n.s. |
Disc diffusion and MIC |
Actinomyces viscosus, Lactobacillus casei, Streptococcus mutans, S. sobrinus, and general oral microbiota |
[99] |
Berries |
Turkey |
n.s. |
Disc diffusion and MIC |
S. epidermidis, S. aureus, B. subtilis, P. aeruginosa, E. coli, and C. albicans |
[100] |
Leaves |
Turkey |
var. communis and var. saxatilis |
MIC |
S. aureus |
[101] |
Leaves |
Poland |
n.s. |
Disc diffusion |
K. pneumoniae, S. enteritidis, P. aeruginosa, A. baumannii, E. faecium, S. aureus, L. fermentum, Clostridium butyricum, L. monocytogenes, B. coagulans, C. utilis, Aspergillus spp., and Fusarium spp. |
[102] |
Stem (branches) |
Italy |
var. communis and var. saxatilis |
Biofilm formation |
S. aureus |
[103] |
Berries |
Turkey |
var. communis and var. saxatilis |
MIC and MLC |
S. aureus, S. epidermidis, E. hirae, B. subtilis, E. coli, P. mirabilis, P. aeruginosa, C. albicans, and C. parapsilosis |
[70] |
Leaves |
India |
n.s. |
MIC |
E. coli, S. aureus, and K. pneumoniae |
[104] |
Antiparasitic activity |
|||||
Essential oils |
|||||
Stems and leaves |
France |
n.s. |
Radioactive micromethod |
Two different strains of Plasmodium falciparum, which were chloroquine-resistant (FcBl) and chloroquine-sensitive (Nigerian) strains |
[105] |
n.s.: not specified; MIC: Minimal inhibitory concentration; MLC: Minimal lethal concentration.
Table 3. In vitro and in vivo antioxidant effects of Juniperus communis extracts.
Part of the Plant |
Origin |
Extract |
Subspecies/ Variety |
Experimental Model |
Effect |
References |
---|---|---|---|---|---|---|
In vitro assay |
||||||
Berries |
Romania |
Ethanolic (50% ethanol, v/v) |
n.s. |
Capacity to scavenge DPPH● |
IC50 value of 1.42 µg/mL |
|
Serbia |
Ethanolic |
IC50 value of 28.55 µg/mL |
||||
Ethyl acetate |
IC50 value of 106.44 µg/mL |
|||||
Chloroform |
IC50 value of 257.66 µg/mL |
|||||
Poland |
Methanolic (70%, methanol v/v) |
IC50 values from 6.86 to 13.66 µg/L |
||||
Essential oils |
IC50 varying from 1.27 to 4.25 µg/L |
|||||
Turkey |
Methanolic |
var. saxatilis |
IC50 value of 1.84 mg/mL |
|||
var. communis |
IC50 value of 0.63 mg/mL |
|||||
Ethanolic (80% ethanol, v/v) |
var. alpina |
Inhibitory percentages of 33.25, 34.27, and 36.26% at 0.5, 1, and 2 mg/mL, respectively |
||||
Aqueous |
Inhibitory percentages of 48.40, 63.29, and 82.03% at 0.5, 1, and 2 mg/mL, respectively |
|||||
Poland |
Methanolic (70% methanol, v/v) |
n.s. |
Reducing power potential |
Values ranging 6.90 and 10.70 mM FeSO4 × 7H2O |
||
Essential oils |
Values ranging from 0.47 and 1.11 mM FeSO4 × 7H2O |
|||||
Turkey |
Methanolic |
var. communis |
IC50 value of 12.82 mg/mL |
|||
12.82 ascorbic acid equivalent/mL |
||||||
var. saxatilis |
IC50 value of 64.14 mg/mL |
|||||
64.14 ascorbic acid equivalent//mL |
||||||
Ethanolic (80% ethanol, v/v) |
var. alpina |
Inhibitory percentages of 0.083, 0.095, and 0.203% at 0.5, 1, and 2 mg/mL, respectively |
||||
Aqueous |
Inhibitory percentages of 0.424, 0.689, and 1.371% at 0.5, 1, and 2 mg/mL, respectively |
|||||
Poland |
Methanolic (70% methanol, v/v) |
n.s. |
β-carotene bleaching test |
β-carotene inhibitory potential varying from 24.36 to 30.63% |
[63] |
|
Essential oils |
n.s. |
β-carotene inhibitory potential varying from 1.19 to 2.39% |
||||
Turkey |
Methanolic |
var. saxatilis |
Protect liposomes from lipid peroxidation |
IC50 value of 120.07 µg/mL |
[70] |
|
var. communis |
IC50 value of 4.44 µg/mL |
|||||
Turkey |
Methanolic |
var. saxatilis |
Ferrous ion (Fe2+)-chelating activity |
Chelating ability around 30% at 2 mg/mL |
||
var. communis |
Chelating ability around 15% at 2 mg/mL |
|||||
Ethanolic (80% ethanol, v/v) |
var. alpina |
Inhibitory percentages of 4.88, 14.86, and 32.82% at 0.5, 1, and 2 mg/mL, respectively |
||||
Aqueous |
Inhibitory percentage of 0.83% at 2 mg/mL |
|||||
Canada |
Ethanolic (80% ethanol, v/v) |
var. communis |
Capacity to scavenge peroxyl radicals |
3876 µM Trolox equivalents at 1 mg/mL |
||
n.s. |
Essential oil |
n.s. |
Capacity to scavenge ABTS•+ species |
IC50 value of 10.96 µg/mL |
||
Turkey |
Ethanolic (80% ethanol, v/v) |
var. saxatilis |
Capacity to scavenge ABTS•+ species |
Inhibitory percentages of 42.5%, respectively at 3 mg/mL |
||
n.s. |
Essential oil |
n.s. |
Capacity to scavenge hydroxyl radicals |
IC50 value of 0.0066 µg/mL |
[32] |
|
n.s. |
Essential oil |
n.s. |
Capacity to scavenge superoxide anions |
IC50 of 0.822 µg/mL |
||
Turkey |
Ethanolic (80% ethanol, v/v) |
var. alpina |
Inhibitory percentages of 20.07, 21.97, and 17.80% at 0.5, 1, and 2 mg/mL, respectively |
|||
Aqueous |
var. alpina |
Inhibitory percentages of 5.49, 10.61, and 11.17% at 0.5, 1 and 2 mg/mL, respectively |
||||
Crushed berries |
Slovakia |
Ethanolic (70% ethanol, v/v) |
n.s. |
Capacity to scavenge hydroxyl radicals |
Inhibitory values varying from 65.59 to 88.12% (recalculated by dry matter (DM), from 3.06 to 5.75%/g DM) |
[67] |
Noncrushed berries |
Slovakia |
Ethanolic (70% ethanol, v/v) |
n.s. |
Inhibitory values varying from 15.52 and 32.85% (recalculated by dry matter (DM), from 1.20 to 20.05%/g DM) for |
||
Unripe berries |
Turkey |
Ethanolic (80% ethanol, v/v) |
var. alpina |
Capacity to scavenge superoxide anions |
Inhibitory percentages of 14.58, 10.99, and 18.37% at 0.5, 1, and 2 mg/mL, respectively |
[61] |
Capacity to scavenge DPPH● |
Inhibitory percentages of 46.21, 57.32, and 73.75% at 0.5, 1, and 2 mg/mL, respectively |
|||||
Capacity to chelate metals |
Inhibitory percentages of 6.32, 5.04, and 16.59% at 0.5, 1, and 2 mg/mL, respectively |
[61] |
||||
Ferric-reducing antioxidant power |
Inhibitory percentages of 0.288, 0.504, and 0.855% at 0.5, 1, and 2 mg/mL, respectively |
|||||
Leaves |
India |
Ethanolic (70% ethanol, v/v) |
n.s. |
Capacity to scavenge DPPH● |
IC50 value of 213 µg/mL |
|
Aqueous |
var. communis |
IC50 value of 347 µg/mL |
||||
Ethyl acetate |
IC50 value of 177 µg/mL |
|||||
Turkey |
Ethanolic (80% ethanol, v/v) |
var. alpina |
Inhibitory percentages of 66.62, 83.06, and 91.40% at 0.5, 1, and 2 mg/mL, respectively |
|||
Aqueous |
Inhibitory percentages of 34.92, 35.56, and 37.29% at 0.5, 1, and 2 mg/mL, respectively |
|||||
Bulgaria |
Methanolic (80% methanol, v/v) |
var. Oblonga Pendula |
IC50 value of 258 µg/mL |
|||
Serbia |
Essential oil |
var. communis |
IC50 value of 660 µg/mL |
|||
Serbia |
Essential oil |
var. saxatilis |
Potential to chelate metals |
IC50 value of 320 µg/mL |
||
India |
Ethyl acetate |
var. communis |
IC50 value of 261 µg/ mL |
|||
Turkey |
Acetate |
n.s. |
Inhibitory effect of 6.05% at 1 mg/mL |
|||
Aqueous |
var. alpina |
Inhibitory percentages of 9.06, 12.39, and 38.40% at 0.5, 1, and 2 mg/mL, respectively |
||||
Turkey |
Ethanolic (80% ethanol, v/v) |
var. alpina |
Capacity to scavenge superoxide anions |
Inhibitory percentages of 20.26, 25.00, and 25.38% at 0.5, 1, and 2 mg/mL, respectively |
||
Turkey |
Ethanolic (80%, ethanol v/v) |
var. alpina |
Ferric-reducing antioxidant power |
Inhibitory percentages of 0.681, 1.278, and 1.971% at 0.5, 1, and 2 mg/mL, respectively |
||
Aqueous |
Inhibitory percentages of 0.121, 0.120, and 0.154% at 0.5, 1, and 2 mg/mL, respectively |
|||||
Serbia |
Distilled extracts |
var. saxatilis |
Reduction capacity of 78.77 mg of ascorbic acid equivalents per g of dry matter |
|||
Serbia |
Distilled extracts |
var. saxatilis |
Lipid-peroxidation inhibitory potential |
IC50 value of 540 µg/mL |
[71] |
|
Essential oils |
IC50 value of 2440 µg/mL |
|||||
Turkey |
Ethanolic (80% ethanol, v/v) |
var. saxatilis |
Capacity to scavenge ABTS•+ species |
Inhibitory percentage of 99.5 at 3 mg/mL |
[66] |
|
Shoots |
Poland |
Crude extract |
n.s. |
Antioxidant-enzyme activity and reactive oxygen species in vitro assays |
↑↑ the activity of intracellular antioxidant enzymes superoxide dismutase and catalase ↓↓ reactive oxygen species |
[56] |
Turkey |
Acetone |
n.s. |
Capacity to chelate metals |
Inhibitory percentage of 6.05% at 1 mg/mL |
[107] |
|
Ethyl acetate |
Inhibitory percentage of 22.59 at 1 mg/mL |
|||||
Ethanolic (75% ethanol, v/v) |
Inhibitory percentage of 12.31% at 1 mg/mL |
|||||
Twigs |
Spain |
Essential oil |
n.s. |
Peroxy-radical-induced oxidation inhibition |
120 µmol Trolox/gram of essential oil |
[53] |
Hops |
Australia |
Ethanolic (30% ethanol, v/v) |
n.s. |
Ferric ion-reducing antioxidant power |
4.17 mg of ascorbic acid equivalents per g |
[68] |
Capacity to scavenge DPPH● |
9.26 mg of ascorbic acid equivalents per g |
|||||
Capacity to scavenge ABTS•+ species |
49.54 mg of ascorbic acid equivalents per g |
|||||
Plant material (twigs, leaves, and berries) |
Spain |
Essential oil |
n.s. |
Reducing power assay |
IC50 values from 135 to 970 µg/mL |
[75] |
Spain |
Essential oil |
n.s. |
Inhibition of oxidation process |
IC50 values from 324.76 to 1563.29 µg/mL |
||
In vivo assay |
||||||
Leaves |
India |
Methanolic |
n.s. |
Effects on Wistar rats with induced Parkinson’s disease by chlorpromazine for 21 days at a dose of 200 mg/kg |
↑↑ in reduced glutathione ↓↓ levels of TBARS |
[19] |
Romania |
Essential oil |
n.s. |
Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42)-induced oxidative stress in Wistar rats |
↑↑ superoxide dismutase and catalase enzymes, and glutathione peroxidase activity |
[85] |
n.s.: not specified; IC50: half-maximal inhibitory concentration; TBARS: thiobarbituric acid-reactive substances, DPPH●: 2,2-diphenyl-1-picrylhydrazyl radical; ABTS•+: 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid; ↑↑: increase; ↓↓: reduction.
Table 4. In vitro and in vivo health benefits of Juniperus communis extracts.
Part of the Plant |
Origin |
Extract |
Subspecies/ Variety |
Experimental Model |
Effect |
References |
---|---|---|---|---|---|---|
Anti-inflammatory and antinociceptive properties |
||||||
In vitro assay |
||||||
Plant parts |
Sweden |
Aqueous |
n.s. |
Prostaglandin biosynthesis assay Platelet activating factor-induced exocytosis assay |
↓↓ prostaglandins by 55% at 200 µg/mL ↓↓ platelet activating factor-induced exocytosis by 78% at 250 µg/mL |
[25] |
Woods |
Austria |
Methylene chloride |
n.s. |
12(S)-lipoxygenase assay |
↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 54.0% at 100 µg/mL, 66.2 and 76.2%, |
[88] |
Berries |
Austria |
Methylene chloride |
n.s. |
↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 66.2% at 100 µg/mL |
||
Ethyl acetate |
↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 76.2% at 100 µg/mL |
|||||
Plant material (twigs, leaves, and fruits) |
Spain |
Essential oil |
n.s. |
Inhibition of nitric oxide production in lipopolysaccharide-activated murine macrophage RAW 264.7 cells |
IC50 values from 23.98 to 84.80 µg/mL |
[75] |
In vivo assays |
||||||
Berries |
Italia |
Hydroethanolic (80% ethanol, v/v) |
var. communis |
Effects on the inhibition of writhing carrageenin foot edema in male Wistar rats after 7 days of treatment at doses of 100 and 200 mg/kg |
↓↓ carrageenin-foot edema by 60% and 79% at 100 and 200 mg/kg, respectively |
[113] |
Turkey |
Aqueous |
12.8% inhibition (berries) |
[114] |
|||
Berries, leaves, and stems |
Turkey |
Methanolic |
var. communis |
18.5% inhibition (stems) 3.9% inhibition (berries) 18.5% inhibition (leaves) |
||
Aqueous |
var. saxatilis |
9.1% inhibition (berries) 7.8% inhibition (leaves) |
||||
Methanolic |
30.5% inhibition (berries) 35.2% inhibition (leaves) |
|||||
Aqueous |
var. communis |
Effects on stimulating response latency in male Swiss albino mice using a hot plate after administration of 100 mg/kg of extract |
4.27% inhibition (stems) 5.36% inhibition (berries) 4.29% inhibition (leaves) |
|||
Methanolic |
4.40% inhibition (stems) 4.11% inhibition (berries) 5.16% inhibition (leaves) |
|||||
Aqueous |
var. saxatilis |
3.26% inhibition (stems) 4.32% inhibition (berries) 5.13% inhibition (leaves) |
||||
Methanolic |
3.13% inhibition (stems) 4.05% inhibition (berries) 5.31% inhibition (leaves) |
|||||
Aqueous |
var. communis |
Effects on carrageenin-induced hind-paw edema in male Swiss albino mice after 360 min of 100 mg/kg extract administration |
65.9% inhibition (stems) 65.1% inhibition (berries) 65.4% inhibition (leaves) |
|||
Methanolic |
54.3% inhibition (stems) 65.8% inhibition (berries) 54.8% inhibition (leaves) |
|||||
Aqueous |
var. saxatilis |
69.6% inhibition (stems) 51.9% inhibition (berries) 53.6% inhibition (leaves) |
||||
Methanolic |
65.7% inhibition (stems) 43.4% inhibition (berries) 45.3% inhibition (leaves) |
|||||
Methanolic |
var. saxatilis |
Effects on PGE2-induced hind-paw edema effects in male Swiss albino mice after 360 min of 100 mg/kg extract administration |
17.6% inhibition (stems) 16.5% inhibition (berries) 16.8% inhibition (leaves) |
|||
Leaves |
India |
Methanolic |
n.s. |
In vivo study involving different nociceptive assays (acetic acid-induced writhing, formalin and tail-flick tests) in Swiss albino mice at 100 and 200 mg/kg |
↓↓ writhing response and the late phase related with the formalin test Act centrally since the extract and pethidine effects were blocked by naloxone in the tail-flick test |
[29] |
Berries |
Romania |
Hydroethanolic microemulsions |
n.s. |
Effects on paw edema in dextran-induced inflammation Wistar rats’ model |
↓↓ paw edema |
[40] |
Berries |
Romania |
Hydroethanolic microemulsions |
n.s. |
Kaolin-induced inflammation in Wistar rats’ model |
↓↓ interleukins -1β and 6 expression ↓↓ tumor necrosis factor alfa |
|
Antidiabetic, antihypercholesterolemic and antihyperlipidemic effects |
||||||
In vitro assays |
||||||
Fruits |
Turkey |
Hydroethanolic (80% ethanol, v/v) |
var. saxatilis |
Capacity to inhibit α-amylase activity |
Inhibitory value of 29.8% at 3 mg/mL |
[66] |
Capacity to inhibit α-glucosidase activity |
IC50 value of 4.4 µg/mL |
|||||
Leaves |
Turkey |
Hydroethanolic (80% ethanol, v/v) |
var. saxatilis |
Capacity to inhibit the α-amylase activity |
Inhibitory value of 84.3% at 3/mg/mL |
|
Capacity to inhibit the α-glucosidase activity |
IC50 value of 53.6 µg/mL |
|||||
Plant material |
United Kingdom |
Aqueous |
n.s. |
Effects on glucose movement |
↓↓ glucose diffusion by 6% at 50 g/L |
[124] |
In vivo assays |
||||||
Berries |
United Kingdom |
n.s. |
Streptozotocin-induced diabetic mice models for 40 days at doses of 1 g/400 mL |
↓↓ polydipsia Prevent weight losses |
[125] |
|
Spain |
Aqueous |
n.s. |
Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at doses of 250 and 500 mg/kg |
↓↓ hypoglycemia in normoglycemic rats |
[126] |
|
Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at 125 mg/kg |
↓↓ blood glucose levels and mortality index Prevent weight losses |
|||||
Turkey |
Oil dissolved in 0.5% of sodium carboxymethyl cellulose |
n.s. |
Effects on albino Wistar rats after 30 days of treatment at doses of 50, 100 and 200 mg/kg |
↓↓ total cholesterol, oxidized low-density lipoprotein, alanine aminotransferase, and aspartate transaminase levels ↑↑ blood urea nitrogen and creatinine levels |
[33] |
|
Plant |
n.s. |
Methanolic extracts |
n.s. |
Effects on streptozotocin-nicotinamide induced diabetic rats after 21 days of treatment at doses of 100 and 200 mg/kg |
↓↓ blood glucose levels, total cholesterol, triglycerides, low-density lipoprotein, and very-low-density lipoprotein cholesterols ↑↑ high-density lipoprotein cholesterol |
[31] |
Herbal preparation also composed of Juniperus. communis |
Croatia |
Hydroethanolic (60% ethanol, v/v) |
n.s. |
Effects on alloxan-induced nonobese diabetic NOD mice after 7 days of treatment at 20 mg/kg |
↓↓ glucose and fructosamine levels |
[127] |
Antiproliferative effects |
||||||
In vitro assays |
||||||
Berries |
Nepal |
Aqueous |
n.s. |
Effects on OECM-1 human gingival squamous cancer cells after 24 h of exposure |
Induce apoptosis, exhibiting an IC50 value of 46.20 µg/mL |
[128] |
Plant material |
n.s |
Aqueous |
n.s |
Effects on CE81T/VGH human esophageal squamous cell carcinoma after 24, 48 and 72 h of exposure |
Induce cell cycle arrest at the G0/G1 phase by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways IC50 values of 68.41, 64.33, and 60.07 µg/mL after 24, 48, and 72 h of exposure, respectively |
[39] |
Effects on CE48T/VGH human esophageal epidermoid carcinoma after 24, 48, and 72 h of exposure |
Induce cell-cycle arrest at the G0/G1 phase, by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways IC50 values of 69.38, 56.96, and 36.10 µg/mL after 24, 48, and 72 h of exposure, respectively |
|||||
USA |
Distilled extracts |
Effects on B16/F10 melanoma cells after 24 and 48 h of exposure |
Induced apoptosis, decreased angiogenesis and metastasis, and diminished cancer stem-cell expression IC50 values of 27 and 44 µg/mL, after 24 and 48 h of exposure, respectively |
[73] |
||
Leaves |
Turkey |
Methanolic |
n.s. |
Effects on C6 rat brain tumor and HeLa human cervix carcinoma cells after 24 h of exposure |
IC50 value of 28.43 µg/mL (C6 rat brain tumor) IC50 value of 32.96 µg/mL (HeLa cancer cells) |
[72] |
Aerial parts |
Egypt |
Methanolic |
n.s. |
Effects on PC3 human prostate, HCT 116 human colon, and MCF7 breast cancer cells after 24 h of exposure |
IC50 value of 23.8 µg/mL (PC3 cancer cells) IC50 value of 37.6 µg/mL (HCT 116 cancer cells) IC50 value of 23.8 µg/mL (MCF7 cancer cells) |
[129] |
Plant material |
New Mexico, USA |
Aqueous |
n.s. |
Effects on MCF-7/AZ breast cancer cells after 24 h of exposure |
IC50 value of 50 µg/mL |
|
Spain |
Essential oil |
n.s. |
Effects on NCI-H460 lung, MCF-7 breast, AGS gastric, and Caco-2 cancer cells after 24 h of exposure |
IC50 values varying from 41.99 to 44.87 µg/mL (NCI-H460 cancer cells) IC50 values varying from 30.88 to 163.99 µg/mL (MCF-7 cancer cells) IC50 values varying from 132.68 to 302.86 µg/mL (AGS cancer cells) IC50 values varying from 107.65 to 230.79 µg/mL (Caco-2 cancer cells) |
||
Berries |
Australia |
Methanolic |
n.s. |
Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure |
IC50 value of 1383 µg/mL (Caco-2 cancer cells) IC50 value of 2592 µg/mL (HeLa cancer cells) |
[131] |
Aqueous |
n.s. |
Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure |
IC50 value of 1516 µg/mL (Caco-2 cancer cells) IC50 value of 2157 µg/mL (HeLa cancer cells) |
|||
Serbia |
Essential oil and Distilled extracts |
var. saxatilis |
Effects on A549 human lung adenocarcinoma epithelial cells after 24 h of treatment after 24 h of exposure |
Induced apoptosis and arrested cell cycle in G2/M IC50 value of 69.4 µg/mL (essential oil) IC50 value 1270 µg/mL (distilled extract) |
[71] |
|
USA |
Distilled extracts |
n.s. |
Effects on HepG2 human hepatocellular cancer cells after 24, 48, and 72 h of exposure |
IC50 values of 48.9, 42.3, and 43.9 µg/mL, after 24, 48, and 72 h of exposure, respectively |
||
Effects on Mahlavu human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure |
IC50 values of 64.9, 58.5, and 59.4 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Effects on J5 human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure |
IC50 values of 74.2, 67.2, and 53.2 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Effects on HT-29 colon cancer cells after 24, 48, and 72 h of exposure |
Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 Induced cell apoptosis via the extrinsic (FasL/Fas/caspase-8) and intrinsic (Bax/Bcl-2/caspase-9) apoptotic pathways IC50 values of 66.71, 60.02, and 54.32 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Effects on CT-26 colon cancer cells after 24, 48, and 72 h of exposure |
Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 Induced cell apoptosis via the extrinsic (FasL/Fas/caspase-8) and intrinsic (Bax/Bcl-2/caspase-9) apoptotic pathways IC50 values of 27.8, 22.7, and 27.3 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Leaves and branches |
Wyoming, USA |
Essential oil |
n.s. |
Effects on SH-SY5Y human neuroblastoma cells after 24 h of exposure |
IC50 value of 53.7 µg/mL |
[134] |
Seed cones |
Serbia |
Essential oil |
var. saxatilis |
Effects on HT-29 and HCT116 colon cancer cells after 24 h of exposure |
IC50 value 125 µg/mL (HT-29) IC50 value of 62.5 µg/mL (HCT116) |
[93] |
Distilled extracts |
IC50 value 625 µg/mL (HT-29) IC50 value of 1250 µg/mL (HCT116) |
|||||
Roots |
China |
Acetone |
n.s. |
Effects on N18 neuroblastoma cell lines after 24 and 48 h of exposure |
Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 values of 61.11 and 68.94 µg/mL, after 24 and 48 h of exposure, respectively |
[135] |
Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 24 h of exposure |
Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 value of 67.04 µg/mL (DBTRG-05MG glioblastoma cells) IC50 value of 63.3 µg/mL (G5T/VGH glioblastoma cells) IC50 value of 57.14 µg/mL (GBM8401glioblastoma cells) IC50 value of 58.45 µg/mL (GBM8901 glioblastoma cells) IC50 value of 69.97 µg/mL (RG2 glioblastoma cells) |
|||||
Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 48 h of exposure |
Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 value of 49.46 µg/mL (DBTRG-05MG glioblastoma cells) IC50 value of 67.85 µg/mL (G5T/VGH glioblastoma cells) IC50 value of 46.68 µg/mL (GBM8401glioblastoma cells) IC50 value of 55.49 µg/mL (GBM8901 glioblastoma cells) IC50 value of 53.8 µg/mL (RG2 glioblastoma cells) |
|||||
In vivo assays |
||||||
Plant |
USA |
Distilled extracts |
n.s. |
Effects on melanoma tumor model in C57BL/6 mice after 23 days of treatment at a dose of 200 mg/kg |
Cell-cycle arrest at the G0/G1 phase ↓↓ tumor size by 45.2%, B-cell lymphoma-2 (Bcl-2), procaspases 8 and 9 and higher levels of Bcl-2-associated X protein, apoptosis-inducing factor, cell-surface death receptor Fas and Fas ligand when compared to untreated control |
[73] |
Berries |
USA |
Distilled extracts |
n.s. |
Effects in BALB/c nude mice injected with HepG2 liver cancer cells at a dose of 200 mg/kg |
↓↓ tumor size ↑↑ lifespan with no or low systemic and pathological toxicity |
[132] |
Effects in female BALB/c mice injected with CT-16 colon cancer cells at a dose of 200 mg/kg |
Inhibited proliferation Induced apoptosis No obvious change in body weight or histological morphology of normal organs after treatment |
[133] |
||||
Roots |
China |
Acetone |
n.s. |
Effects in male Foxn1 nu/nu mice injected with DBTRG-05MG human glioblastoma cells after 100 days of treatment at a dose of 200 mg/kg |
Can penetrate the blood-brain barrier ↓↓ tumor size and the degree of neovascularization ↑↑ PCNA, VEGFR-1, and VEGFR-2 in 44.49%, 5.88%, and 5.85%, respectively, when compared to untreated control |
[135] |
Neuronal effects and anticataleptic activity |
||||||
In vitro assays |
||||||
Leaves |
Turkey |
Hydroethanolic (80% ethanol, v/v) |
var. alpina |
Capacity to inhibit acetylcholinesterase activity |
10.38% inhibition at 50 µg/mL 24.30% inhibition at 100 µg/mL 32.89% inhibition at 200 µg/mL |
|
Ripe Berries |
Aqueous |
5.47% inhibition at 100 µg/mL 28.17% inhibition at 200 µg/mL |
||||
Shoots |
Ethyl acetate, ethanolic, and acetone extracts |
n.s. |
21.34% inhibition at 100 µg/mL (ethyl acetate extract) 13.46% inhibition at 100 µg/mL (ethanolic extract) 28.43% inhibition at 100 µg/mL (acetone extract) |
|||
Inhibitory percentages varying from 32.34 to 41.97%% inhibition at 100 µg/mL (ethyl acetate extract) Inhibitory percentages varying from 22.29 to 45.45% inhibition at 100 µg/mL (ethanolic extract) Inhibitory percentages varying from 1.91 to 38.55% inhibition at 100 µg/mL (acetone extract) |
||||||
Leaves |
Ethyl acetate, ethanolic, and acetone extracts |
n.s. |
20.02% inhibition at 100 µg/mL (ethyl acetate extract) 10.56% inhibition at 100 µg/mL (ethanolic extract) 32.34% inhibition at 100 µg/mL (acetone extract) |
|||
Ripe berries and leaves |
Turkey |
Aqueous |
var. alpina |
Capacity to inhibit butyrylcholinesterase activity |
25.87 (berries) and 25.33% (leaves) inhibition at 50 µg/mL 32.57 (berries) and 44.16% (leaves) inhibition at 100 µg/mL 36.97 (berries) and 62.01% (leaves) inhibition at 200 µg/mL |
|
Hydroethanolic (80% ethanol, v/v) |
43.68 (berries) and 30.31% (leaves) inhibition at 50 µg/mL 45.19 (berries) and 33.17% (leaves) inhibition at 100 µg/mL 47.55 (berries) and 35.33% (leaves) inhibition at 200 µg/mL |
|||||
Unripe berries |
Hydroethanolic (80% ethanol, v/v) |
44.17% inhibition at 50 µg/mL 48.96% inhibition at 100 µg/mL 49.95% inhibition at 200 µg/mL |
||||
In vivo assays |
||||||
Leaves |
n.s. |
Methanolic |
n.s. |
Effects on Wistar rats with induced Parkinson’s disease by chlorpromazine for 21 days at a dose of 200 mg/kg |
↑↑ locomotor activity ↓↓ motor dysfunctions, including catalepsy and muscle rigidity |
[19] |
Plant material |
India |
Methanolic |
Effects on Wistar rats with induced catalepsy by reserpine 4 h after juniper treatment at a dose of 200 mg/kg |
↓↓ catalepsy activity |
[34] |
|
Romania |
Essential oil |
Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42) male Wistar rat model of Alzheimer’s disease after 21 days of treatment |
↑↑ working memory and reference memory errors within radial arm maze task ↓↓ spontaneous alternations percentage within Y-maze task |
[136] |
||
Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42)-induced oxidative stress in Wistar rats |
↑↑ acetylcholinesterase, superoxide dismutase and catalase activities, and malondialdehyde and protein carbonyl levels ↓↓ glutathione peroxidase-specific activity and the total content of the reduced glutathione |
[85] |
||||
Hepatoprotective effects |
||||||
In vivo assays |
||||||
Leaves |
India |
Ethyl acetate |
n.s. |
Effects on Wistar albino rats with hepatic damage caused by paracetamol for 14 days at a dose of 200 mg/kg |
↓↓ alkaline phosphatase (−57.41%), direct bilirubin (−30.33%) and total bilirubin (−38.41%), serum alanine aminotransferase (−34.17%), and serum aspartate aminotransferase (−27.58%) when compared to the untreated group Hepatoprotective effects with rearrangement promotion of portal triads and central veins |
[65] |
Stems |
n.s. |
Petroleum ether, chloroform, and ethanol extracts |
n.s. |
Effects on rats with hepatic damage caused by carbon tetrachloride |
Hepatoprotective activity |
[30] |
Co-combination of berries from juniper and Solanum xanthocarpum |
India |
Ethanolic |
n.s. |
Effects on Wistar albino rats with liver toxicity induced by paracetamol and azithromycin for 14 days at a dose of 200 mg/kg |
↓↓ serum glutamate oxaloacetate transaminase (−65.4%), serum glutamate pyruvate transaminase (−59.3%), alkaline phosphatase (66.8%), total bilirubin (62.1%), and liver inflammation Promoting liver tissue’s normal architecture |
[3] |
Tyrosinase inhibitory activity |
||||||
In vitro assays |
||||||
Berries |
Republic of Korea |
Methanolic |
n.s. |
Capacity to inhibit tyrosinase activity |
about 50% inhibition at 100 µg/mL |
[137] |
Renal effects |
||||||
In vivo assay |
||||||
Berries |
Croatia |
Aqueous |
n.s. |
Daily intake of 10% aqueous infusion, 0.1% of oil (with 0.2% Tween 20 solubilizer) by healthy female Wistar rats |
↑↑ diuresis and urine excretion without loss of electrolytes |
[86] |
Antiurolithiasis effects |
||||||
In vitro assay |
||||||
Berries |
Iran |
Hydroethanolic (50% ethanol, v/v) |
n.s. |
Capacity to dissolve urinary stone brought out from human kidney at concentrations of 500, 1000, and 2000 µg/mL |
Dissolve urinary stones ↓↓ dry powder weight of stones ↑↑ the ratio of calcium oxalate in normal saline aqueous solution plus stone |
[138] |
Gastrointestinal effects |
||||||
In vivo assays |
||||||
Leaves |
India |
Methanolic (80% methanol, v/v) |
n.s. |
Effects on adult male Wistar albino rats with ulcers induced by aspirin, serotonin, indomethacin, alcohol, and stress at doses of 50 and 100 mg/kg |
↓↓ aspirin, serotonin, indomethacin, alcohol, and stress-induced gastric ulcerations in rats ↑↑ healing rate of acetic acid-induced ulcers in rats |
[87] |
n.s. |
Effects on pigs with histamine-induced duodenal lesions at doses of 50 and 100 mg/kg |
↓↓ histamine-induced duodenal lesions in pigs |
||||
Vessels and trachea protective effects in passive smoking |
||||||
In vitro assays |
||||||
Berries |
Romania |
Aerosols |
n.s. |
Effects of 3-week juniper aerosols (40 min/day) on female Sprague-Dawley rats firstly exposed to daily passive smoking for 6 weeks |
↓↓ acetylcholine endothelial-dependent relaxation |
[139] |
Oil |
n.s. |
Effects of 3-week juniper nebulization (20 min/day) on the respiratory tract of rats which firstly exposed to 2 cigarettes per day, 5 days a week for 6 weeks |
Bronchodilator effects mediated by nitric oxide |
[140] |
||
Genotoxicity protective effects |
||||||
In vitro assays |
||||||
Berries |
Romania |
Hydroethanolic (50% ethanol, v/v) |
n.s. |
Capacity to exhibit genoprotective effects against aberrations and abnormalities induced by ethanol on root-tip cells of Allium cepa L. |
Can effectively protect chromosomes aberrations |
[40] |
n.s.: not specified; IC50: half-maximal inhibitory concentration ↑↑: increase; ↓↓: reduction.
This entry is adapted from the peer-reviewed paper 10.3390/ijms23063197